Clinically, strong correlations have been observed between IFN-β plasma levels and clinical disease scores, while IFN-α levels only correlated with disease scores in anti-MDA5+ patients, a subtype of JDM with distinct clinical and pathological features [36]. This evidence concerns the gene IFNA1 and juvenile dermatomyositis.